Xbiome
Manufacturing · China · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Scientific Research Building Tsinghua In...Phone Number
+86 75586530994Website
www.xbiome.comRevenue
$21.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Xbiome
Xbiome is an AI pharmaceutical company in the domestic industry that focuses on intestinal microbial treatment. Established in 2017, Xbiome is headquartered in Guangdong, China.Explore more
Xbiome Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xbiome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Xbiome
Product Launch: Get notified when Xbiome launches new products
Click to see if Xbiome had a recent Job posting/layoffs
Check if Xbiome has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Xbiome recently announced quarterly report
Xbiome, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Xbiome is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Xbiome has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Xbiome
Find 2 more new buyers
Company Profile Activity
Activity Insights
Xbiome is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xbiome is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xbiome.
Xbiome financials insights
Gather financial insights about Xbiome, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series B
$100M
Xbiome Tech Stack
A closer look at the technologies used by Xbiome
Xbiome News & Media
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China
BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 28, 2022 /PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the...Chinese AI-based drug maker Xbiome bags nearly $100m in Series B round - DealStreetAsia
The fresh round saw participation from investors including 5Y Capital, Legend Capital, Primavera Capital, Gaorong Capital, and HIKE Capital.
Read more news
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Xbiome
Sign Up For FreeTo access detailed company insights
Xbiome is an AI pharmaceutical company in the domestic industry that focuses on intestinal microbial treatment. Established in 2017, Xbiome is headquartered in Guangdong, China.... Read More
